The effects of the aromatase inhibitor fadrozole hydrochloride on fetuses and uteri in late pregnant rats.
نویسندگان
چکیده
It is well known that progesterone and estrogen are essential hormones for maintaining pregnancy in most mammals. Some specific roles of progesterone for the maintenance of pregnancy have been clarified, but the role of estrogen is not well known. This study examines the effects of the aromatase inhibitor, fadrozole hydrochloride (Fad), on fetuses, uterine physical properties and the mRNA expression of the uterine enzymes that are related to collagen metabolism during late pregnancy in rats. Continuous s.c. infusion with 300 micro g/day Fad from day 14 of pregnancy (day 1=the day of sperm detection) reduced the concentration of plasma estradiol-17beta (E(2)), and did not change that of plasma progesterone, compared with controls. The treatment increased the intrauterine pressure and reduced the size and compliance of the uterine tissue framework. It also caused injuries (hematomata on the extremities) in about one-quarter of fetuses by day 20. The collagen content of the uterine ampullae was not changed by the treatment. Uterine mRNA expressions of matrix metalloproteinase-1 (MMP-1), which degrades collagens, and of lysyl oxidase (LO), which is necessary for the formation of intra- and inter-molecular cross-links of collagen, were examined by quantitative RT-PCR. The treatment with Fad had no effect on the expression of MMP-1 mRNA and increased that of LO mRNA. Daily s.c. injection with 0.2 micro g E(2) restored the changes in uterine physical properties and the mRNA expression of LO caused by the Fad treatment, and prevented fetal injury, indicating that the influences of Fad treatment are due to estrogen deficiency but not to toxicological effects of Fad. These results imply that estrogen deficiency during late pregnancy in rats obstructs development of the uterine tissue framework so as to cause fetal injury. It is possible that an increase in the uterine expression of LO gene may be involved in this obstruction.
منابع مشابه
The Effect of in ovo Injection of Aromatase Inhibitors on the Performance of Broilers
Change in sex ratios for broiler chickens, has many economic benefits of the poultry industry. The gonads in chick embryo at an early stage have the potential to convert to both sexes (male and female). Sexual differentiation is due to aromatase expression in the left gonad in 5-6 days of the embryonic period and the production of estrogen from testosterone. Administration of aromatase inhibito...
متن کاملاثر تزریق داخل تخم مرغی عصاره چای سبز و هیدروکلراید فدرازول بر تغییر جنسیت و ساختار ماهیچه ای جوجه های گوشتی
In the present study 252 fertile eggs from Ross 308 strin broiler breeders flock were divided into three experimental group and at 5th day of incubation period were in ovo injected into the air cell by 0.1 ml of green tea extract, fadrozole hydrochloride or distilled water. The hatched chickens then were arranged based on the experimental groups of incubation period in a completely randomized d...
متن کاملAromatase inhibitors as potential cancer chemopreventives.
Epidemiological and experimental evidence strongly supports a role for estrogens in the development and growth of breast tumors. A role for estrogen in prostate neoplasia has also been postulated. Therefore, one chemopreventive strategy for breast and prostate cancers is to decrease estrogen production. This can be accomplished by inhibiting aromatase, the enzyme that catalyzes the final, rate-...
متن کاملThe Effects of L-arginine on the Hippocampus of Male Rat Fetuses under Maternal Stress
Introduction: Prenatal stress has deleterious effects on the development of the brain and is associated with behavioral and psychosocial problems in childhood and adulthood. This study aimed to determine the protective effect of L-arginine on fetal brain under maternal stress. Methods: Twenty pregnant Wistar rats (weighting 200-230 g) were randomly divided into 4 groups (n=5 for each group). T...
متن کاملPhase I Study of the Oral Nonsteroidal Aromatase Inhibitor CGS 20267 in Postmenopausal Patients with Advanced Breast Cancer
A phase I study was performed of CGS 20267, an oral nonsteroidai, highly potent, and selective aromatase inhibitor, in 21 postmenopausal patients with advanced breast cancer. The patients were recruited in 3 successive groups of 7, receiving 0.1, 0.5, and 2.5 mg p.oJday, respectively. All patients had received at least one prior endocrine treatment (range, 1-4), and six patients had received pr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of endocrinology
دوره 180 2 شماره
صفحات -
تاریخ انتشار 2004